Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
Trends in Cancer
|
November 10, 2017
Doubling Down on BRCA-Mutated Cancer
Andrea E Wahner Hendrickson, Scott H Kaufmann, Elizabeth M Swisher
Cancer Medicine
|
May 12, 2016
Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta-analysis of anti-CTLA-4 and anti-PD-1 agents trials
Seongseok Yun, Nicole D Vincelette, Myke R Green, et al.
Journal of Palliative Medicine
|
May 25, 2018
Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients
Jason D Doles, Kelly A Hogan, Jennifer O'Connor, et al.
Cancer Research
|
April 4, 2013
ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status
Catherine J Huntoon, Karen S Flatten, Andrea E Wahner Hendrickson, et al.
Investigational New Drugs
|
April 2, 2013
Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies
Erin Schenk, Andrea E Wahner Hendrickson, Donald Northfelt, et al.
Rare Tumors
|
May 7, 2021
An unusual case of aggressive malignant spread of epithelioid hemangioendothelioma
Ashley D Hickman, Evandro D Bezerra, Anja C Roden, et al.
Current Treatment Options in Cardiovascular Medicine
|
March 3, 2018
Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers
Kelly C Gast, Paul V Viscuse, Somaira Nowsheen, et al.
Gynecologic Oncology
|
June 15, 2026
Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomes
Riham Suleiman, Shilpa Mokshagundam, Matthew S Block, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 4, 2021
Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization
Upasana Ray, Debarshi Roy, Ling Jin, et al.
Gynecologic Oncology
|
July 13, 2023
Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
Anousheh Shafa, A Brooke Watkins, Michaela E McGree, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
Trends in Cancer
|
November 10, 2017
Doubling Down on BRCA-Mutated Cancer
Andrea E Wahner Hendrickson, Scott H Kaufmann, Elizabeth M Swisher
Cancer Medicine
|
May 12, 2016
Targeting immune checkpoints in unresectable metastatic cutaneous melanoma: a systematic review and meta-analysis of anti-CTLA-4 and anti-PD-1 agents trials
Seongseok Yun, Nicole D Vincelette, Myke R Green, et al.
Journal of Palliative Medicine
|
May 25, 2018
Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients
Jason D Doles, Kelly A Hogan, Jennifer O'Connor, et al.
Cancer Research
|
April 4, 2013
ATR inhibition broadly sensitizes ovarian cancer cells to chemotherapy independent of BRCA status
Catherine J Huntoon, Karen S Flatten, Andrea E Wahner Hendrickson, et al.
Investigational New Drugs
|
April 2, 2013
Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies
Erin Schenk, Andrea E Wahner Hendrickson, Donald Northfelt, et al.
Rare Tumors
|
May 7, 2021
An unusual case of aggressive malignant spread of epithelioid hemangioendothelioma
Ashley D Hickman, Evandro D Bezerra, Anja C Roden, et al.
Current Treatment Options in Cardiovascular Medicine
|
March 3, 2018
Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers
Kelly C Gast, Paul V Viscuse, Somaira Nowsheen, et al.
Gynecologic Oncology
|
June 15, 2026
Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomes
Riham Suleiman, Shilpa Mokshagundam, Matthew S Block, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 4, 2021
Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization
Upasana Ray, Debarshi Roy, Ling Jin, et al.
Gynecologic Oncology
|
July 13, 2023
Incidence of venous thromboembolism in patients with advanced stage ovarian cancer undergoing neoadjuvant chemotherapy: Is it time for thromboprophylaxis?
Anousheh Shafa, A Brooke Watkins, Michaela E McGree, et al.
Page
of 6